Literature DB >> 10160519

Information, marketing, and pricing in the U.S. antiulcer drug market.

E R Berndt1, L Bui, D R Reiley, G L Urban.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 10160519

Source DB:  PubMed          Journal:  Am Econ Rev        ISSN: 0002-8282


× No keyword cloud information.
  13 in total

1.  Price-cost margin in the pharmaceutical industry. Empirical evidence from Finland.

Authors:  Ismo Linnosmaa; Raine Hermans; Taru Hallinen
Journal:  Eur J Health Econ       Date:  2004-06

2.  Preferred supplier contracts in post-patent prescription drug markets.

Authors:  Carl Rudolf Blankart; Tom Stargardt
Journal:  Health Care Manag Sci       Date:  2016-02-22

3.  Changes in physician antipsychotic prescribing preferences, 2002-2007.

Authors:  Julie Donohue; A James O'Malley; Marcela Horvitz-Lennon; Anna Levine Taub; Ernst R Berndt; Haiden A Huskamp
Journal:  Psychiatr Serv       Date:  2014-03-01       Impact factor: 3.084

4.  The Impact Of Academic Medical Center Policies Restricting Direct-To-Physician Marketing On Opioid Prescribing.

Authors:  Matthew D Eisenberg; Elizabeth M Stone; Harlan Pittell; Emma E McGinty
Journal:  Health Aff (Millwood)       Date:  2020-06       Impact factor: 6.301

5.  Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications.

Authors:  Stacy W Gray; Katrina Armstrong; Angela Demichele; J Sanford Schwartz; Robert C Hornik
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

6.  Antipsychotic prescribing: do conflict of interest policies make a difference?

Authors:  Timothy S Anderson; Haiden A Huskamp; Andrew J Epstein; Colleen L Barry; Aiju Men; Ernst R Berndt; Marcela Horvitz-Lennon; Sharon-Lise Normand; Julie M Donohue
Journal:  Med Care       Date:  2015-04       Impact factor: 2.983

7.  Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes.

Authors:  Yi-Wen Tsai; Yu-Wen Wen; Weng-Foung Huang; Ken N Kuo; Pei-Fen Chen; Hsin-Wei Shih; Yue-Chune Lee
Journal:  Eur J Health Econ       Date:  2009-08-02

8.  The Price Elasticity of Specialty Drug Use: Evidence from Cancer Patients in Medicare Part D.

Authors:  Jeah Kyoungrae Jung; Roger Feldman; A Marshall McBean
Journal:  Forum Health Econ Policy       Date:  2017-05-26

9.  Pharmaceutical advertising and Medicare Part D.

Authors:  Darius Lakdawalla; Neeraj Sood; Qian Gu
Journal:  J Health Econ       Date:  2013-12       Impact factor: 3.883

10.  Diffusion patterns of new anti-diabetic drugs into hospitals in Taiwan: the case of thiazolidinediones for diabetes.

Authors:  Yu-Wen Wen; Weng-Foung Huang; Yue-Chune Lee; Ken N Kuo; Chia-Rung Tsai; Yi-Wen Tsai
Journal:  BMC Health Serv Res       Date:  2011-01-31       Impact factor: 2.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.